Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis-specific transcript, Y-linked 6B (TTTY6B) is a long intergenic non-coding RNA (lincRNA) located on the human Y chromosome. It does not encode a protein and is classified as a non-coding RNA, specifically a lincRNA, which is a subclass of long non-coding RNAs (lncRNAs) longer than 200 nucleotides and located outside known protein-coding loci[1][3][7]. Although lincRNAs as a class are increasingly recognized to regulate gene transcription, chromatin state, and possibly act as molecular scaffolds, the biological function of TTTY6B itself remains largely uncharacterized. It is sometimes referred to by its alternative names, including LINC00128 and NCRNA00128. There is currently no evidence that TTTY6B is a drug target, nor is it directly implicated as a biomarker or as having a disease association. Its expression appears to be restricted to testis, fitting with its annotation as "testis-specific"[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis-specific transcript, Y-linked 6B (TTTY6B).